Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Table 2

Characteristics of propensity score-matched patient treated with PEG-IFN plus RBV or daclatasvir plus asunaprevir.

Table 2